Key Insights

Highlights

Success Rate

75% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

13.3%

2 terminated out of 15 trials

Success Rate

75.0%

-11.5% vs benchmark

Late-Stage Pipeline

13%

2 trials in Phase 3/4

Results Transparency

17%

1 of 6 completed with results

Key Signals

1 with results75% success

Data Visualizations

Phase Distribution

8Total
Not Applicable (4)
P 1 (2)
P 4 (2)

Trial Status

Completed6
Unknown4
Terminated2
Suspended1
Withdrawn1
Recruiting1

Trial Success Rate

75.0%

Benchmark: 86.5%

Based on 6 completed trials

Clinical Trials (15)

Showing 15 of 15 trials
NCT05384899Completed

Kidney Precision Medicine Project (KPMP) - COVID-19 Protocol

NCT04334707Recruiting

Kidney Precision Medicine Project

NCT06791304CompletedPrimary

Renal Resistive Index in Early Detection of Postoperative Acute Kidney Injury

NCT03311256CompletedPrimary

Determination of the "Tissue Transit Time" (TTT)

NCT05240833Not ApplicableUnknown

VExUS-guided Fluid Management in Patients With Acute Kidney Injury in the Intensive Care Unit

NCT02531724Phase 4Completed

Effects of Levosimendan in Acute Kidney Injury After Cardiac Surgery

NCT04605705UnknownPrimary

NIRS for the Diagnosis and Prevention of Acute Renal Failure

NCT02808052Phase 1TerminatedPrimary

Evaluate Safety and Pharmacokinetics of Minocin (Minocycline) for Injection in Subjects With Renal Insufficiency

NCT03489759Not ApplicableUnknown

The Effect of Vitamin E-coated Polysulfone Membrane on Oxidative Stress, Inflammation and Monocytes in Critically Ill Patients in CRRT

NCT03136315Not ApplicableCompletedPrimary

Evaluation of the Renal Function in an Ultra-endurance Race.

NCT00855127WithdrawnPrimary

New Urine and Blood Markers for Acute Kidney Injury in Liver Transplant Patients

NCT01233882Phase 1Completed

Bosutinib In Subjects With Renal Impairment

NCT00806039Not ApplicableUnknown

Impact of Early Renal Involvement on the Development of Severe In-hospital Renal Failure

NCT00190034Phase 4Suspended

Acetylcysteine Against Acute Renal Insult During Cardiopulmonary Bypass.

NCT00322933TerminatedPrimary

Intermittent Versus Continuous Renal Replacement Therapy for Acute Renal Failure

Showing all 15 trials

Research Network

Activity Timeline